NCT00833469

Escitalopram (Lexapro) for the Treatment of Postpartum Depression

Escitalopram for the Treatment of Postpartum Depression

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 7 (actual)
• Sponsor: Massachusetts General Hospital · Academic / Other
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether women with postpartum major depressive disorder (MDD) will experience a significant decrease in depressive symptoms from baseline over an eight-week treatment intervention with escitalopram (Lexapro). Also, to determine whether women with postpartum MDD will experience a significant decrease in anxiety symptoms.

Conditions

• Postpartum Depression

Interventions

Type	Name	Description
DRUG	Escitalopram	Once daily by mouth

Timeline

• Start date: 2009-01-01
• Primary completion: 2011-04-01
• Completion: 2011-04-01
• First posted: 2009-02-02
• Last updated: 2014-08-06
• Results posted: 2014-08-06

Locations

1 site across 1 country: United States